A recent trial published in the Journal of American Medical Association found that subthalamic deep brain stimulation (DBS) ...
Recently FDA-cleared, adaptive deep brain stimulation is gaining global traction, offering real-time, personalized therapy for Parkinson’s disease.
Medtronic (NYSE: MDT) today announced study results backing its adaptive DBS algorithm for personalized therapy in ...
Deep brain stimulation in patients with Parkinson’s disease is linked to significant motor and daily living improvements 5 ...
The St. Jude Medical Infinity™ Deep Brain Stimulation (DBS) system with directional lead technology is designed to help patients with Parkinson’s disease or essential tremor gain control of their ...
Medtronic plc MDT recently announced receipt of the FDA’s approval for its Percept PC Deep Brain Stimulation (“DBS”) system. The inclusion of the BrainSense technology with the Percept PC DBS system ...
Liberta RC DBS system is about 31% smaller than other commonly used devices in the U.S. The Liberta RC DBS system requires the fewest recharges of any FDA-approved DBS system. Get the Strategy to ...
Boston Scientific Corporation BSX recently announced the receipt of the FDA’s approval for its fourth-generation Vercise Genus Deep Brain Stimulation (“DBS”) System. Notably, the DBS portfolio is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback